1998
DOI: 10.1046/j.1460-9568.1998.00192.x
|View full text |Cite
|
Sign up to set email alerts
|

GFRα‐3, a protein related to GFRα‐1, is expressed in developing peripheral neurons and ensheathing cells

Abstract: We report here the identification of a gene, termed GFRalpha-3 (glial cell line-derived neurotrophic factor family receptor alpha-3), related to GFRalpha-1 and GFRalpha-2 (also known as GDNFR-alpha and GDNFR-beta), and describe distribution of GDNFalpha-3 in the nervous system and other parts of the mouse body during development and in the adult. GFRalpha-3 in situ hybridization signals were found mainly in the peripheral nervous system, with prominent signals in developing dorsal root and trigeminal ganglia. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
26
2

Year Published

1998
1998
2014
2014

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(31 citation statements)
references
References 21 publications
3
26
2
Order By: Relevance
“…The high affinity ART receptor is clearly GFRα-3, but neither a competing laboratory (Masure et al, 1999) nor our data (Figures 4, 5) corroborate a proposed low affinity ART-GFRα-1 pairing Milbrandt et al, 1998). However, it cannot be ruled out that supraphysiological ART concentrations might mediate productive signaling through other GFRα receptors, a possibility supported by the upregulation of ART in rat striatum ipsilateral to a chemical lesion (Zhou et al, 2000) and the capacity of ART gene therapy to ameliorate chemical lesions to mesencephalic dopaminergic neurons (Rosenblad et al, 2000) despite very low levels (Stover et al, 2000) or absence (Naveilhan et al, 1998;Widenfalk et al, 1998) of GFRα-3 expression at this site. Further work is needed to resolve this question.…”
Section: Recombinant Art Does Not Relieve Neuropathic Paincontrasting
confidence: 56%
“…The high affinity ART receptor is clearly GFRα-3, but neither a competing laboratory (Masure et al, 1999) nor our data (Figures 4, 5) corroborate a proposed low affinity ART-GFRα-1 pairing Milbrandt et al, 1998). However, it cannot be ruled out that supraphysiological ART concentrations might mediate productive signaling through other GFRα receptors, a possibility supported by the upregulation of ART in rat striatum ipsilateral to a chemical lesion (Zhou et al, 2000) and the capacity of ART gene therapy to ameliorate chemical lesions to mesencephalic dopaminergic neurons (Rosenblad et al, 2000) despite very low levels (Stover et al, 2000) or absence (Naveilhan et al, 1998;Widenfalk et al, 1998) of GFRα-3 expression at this site. Further work is needed to resolve this question.…”
Section: Recombinant Art Does Not Relieve Neuropathic Paincontrasting
confidence: 56%
“…Of these, Abcb1a is a membrane transporter whereas the others are involved in development [41]. Chrna3, Cspg4, Daam2, and Gfra3 play roles in nervous system development [42][43][44][45][46], while Aebp1 is required for smooth muscle formation [47][48][49][50]. We verified the low level of DNA methylation in two different ESC lines, which contrasted with the high DNA methylation level (90%-98% methylated CpGs) in two EpiSC lines (Fig.…”
Section: Identification and Characteristics Of Differentially Methylamentioning
confidence: 74%
“…Different groups (18)(19)(20)(21)(22) have reported the cloning of the GFRα3 receptor. The ligand for GFRα3, ART, was recently shown to bind to GFRα3 receptor and to be a survival factor for different sensory and sympathetic neurons (23).…”
Section: I]-mentioning
confidence: 99%